Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.resmer.2020.100769 http://scihub22266oqcxt.onion/10.1016/j.resmer.2020.100769 32563968!7246014!32563968     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Respir+Med+Res 2020 ; 78 (ä): 100769 Nephropedia Template TP {{tp|p=32563968|t=2020. Proposals for managing patients with thoracic malignancies during COVID-19 pandemic |pdf=|usr=}}{{32563968}} gab.com Text Proposals for managing patients with thoracic malignancies during COVID-19 pandemic JO: Respir Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32563968 #FOAvip The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF)/French-language oncology group. These proposals are evolving (10 April 2020) according to the situations encountered, which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic. Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels. Twit Text FOAVip Proposals for managing patients with thoracic malignancies during COVID-19 pandemic ????Respir Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32563968 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32563968 #FOAvip English Wikipedia <ref>{{Cite pmid|32563968}}</ref> Proposals for managing patients with thoracic malignancies during COVID-19 pandemic #MMPMID32563968 Girard N; Greillier L; Zalcman G; Cadranel J; Moro-Sibilot D; Mazieres J; Audigier-Valette C; Bennouna J; Besse B; Cortot A; Couraud S; Duruisseaux M; Giroux-Leprieur E; Toffart AC; Westeel V; Wislez M Respir Med Res 2020[Nov]; 78 (ä): 100769 PMID32563968show ga The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF)/French-language oncology group. These proposals are evolving (10 April 2020) according to the situations encountered, which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic. Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels. |*Pandemics[MESH] |Antineoplastic Agents/therapeutic use[MESH] |COVID-19/complications/*epidemiology/*prevention & control[MESH] |Chemoradiotherapy/methods/standards[MESH] |Clinical Trials as Topic/methods/organization & administration/standards[MESH] |Humans[MESH] |Mutation[MESH] |Neoadjuvant Therapy/methods/standards[MESH] |Neoplasm Metastasis[MESH] |Pulmonary Medicine/methods/organization & administration/standards[MESH] |Risk Factors[MESH] |Risk Reduction Behavior[MESH] |SARS-CoV-2[MESH] |Thoracic Neoplasms/epidemiology/genetics/pathology/*therapy[MESH]Proposals for managing patients with thoracic malignancies during COVI(epmc).pdf DeepDyve Pubget Overpricing